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Abstract
Background: Microarray technology has become highly valuable for identifying complex global changes in gene expression 
patterns. The assignment of functional information to these complex patterns remains a challenging task in effectively interpreting 
data and correlating results from across experiments, projects and laboratories. Methods which allow the rapid and robust evaluation 
of multiple functional hypotheses increase the power of individual researchers to data mine gene expression data more efﬁ  ciently.
Results: We have developed (gene set matrix analysis) GSMA as a useful method for the rapid testing of group-wise up- or down-
regulation of gene expression simultaneously for multiple lists of genes (gene sets) against entire distributions of gene expression 
changes (datasets) for single or multiple experiments. The utility of GSMA lies in its ﬂ  exibility to rapidly poll gene sets related 
by known biological function or as designated solely by the end-user against large numbers of datasets simultaneously.
Conclusions: GSMA provides a simple and straightforward method for hypothesis testing in which genes are tested by 
groups across multiple datasets for patterns of expression enrichment.
Background
Assigning functional meaning to patterns of statistically signiﬁ  cant changes in gene expression is a 
common goal in the interpretation of microarray data. Until recently most conventional approaches 
have restricted their focus to only those genes which have satisﬁ  ed multiple different criteria including 
size of fold change, signiﬁ  cant p-value (often accompanied by additional requirements related to pass-
ing tests correcting for multiple comparisons), and certain minimum baseline levels of expression on 
at least one side of the comparison. This approach was reasonable during the early developmental period 
of microarrays when uncertainty as to the reliability of gene expression measurements naturally led to 
a conservative bias in the interpretation of microarray data in an effort to reduce, as much as possible, 
the inclusion of artifactual noise in analyses. Unfortunately, the tradeoff in reducing Type 1 error 
(false positives) was almost certainly at the expense of increasing Type II error (false negatives) but since 
these were essentially unknown, the problem tended to be ignored at that time. The issue has become 
more acute as technical improvements in microarray technology and the extent and depth of microarray 
studies have expanded at accelerated rates. The loss of vital information because of restrictive signiﬁ  cance 
levels is less tolerable and, as others have argued, can result in the failure to deﬁ  ne small but coordinated 
changes in gene expression which clearly, in the aggregate, distinguish biological phenotypes [1].
Traditional methods of assigning function to gene lists have focused primarily in looking for 
enrichment within a group of genes on the basis of some functional category, for example, for gene 
ontologies (GenMapp, David/Ease) or pathways (KEGG, BioCarta). These methods use some simple 
statistic (e.g. Fisher’s exact test) to generate an estimate of probability that the genes are enriched rela-
tive to all genes for that category and corrected for the frequency of representation for the genes of that 
category on the microarray platform being used. These methods are vulnerable to small changes in the 50
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genelist composition even among highly related 
experiments as a result of natural variation in the 
expression of genes close to preset signiﬁ  cance 
thresholds. In addition, these methods tend to 
under-represent the population of truly regulated 
genes for a given category, again because of arbi-
trary signiﬁ  cance thresholds, thus reducing the 
overall power of the analyses.
Recent, more promising developments in micro-
array data analysis have succeeded where more 
traditional methods have failed [2] primarily as a 
result of inverting the analysis paradigm. Instead of 
examining a restricted list of genes selected by sig-
niﬁ  cance criteria for the enrichment of functionally 
related genes, these alternative methods take pre-
determined gene lists (or gene sets) often derived as 
described above (e.g. GO categories, pathways, 
common promoter elements) and use these gene sets 
to poll an entire dataset of gene expression changes. 
In this way, all the data is taken into consideration 
when computing enrichment statistics, and all the 
individual values of the particular difference met-
ric used are taken into account. Gene sets derived 
from empirically determined gene expression sig-
natures based solely on experimental data can also 
be used to interrogate additional datasets and dem-
onstrate shared common patterns [3]. In fact, 
because of this unique ability to comprehensively 
compare gene expression results between experi-
ments, we propose that these methods be referred 
to, in general, as gene expression signature analy-
ses in order to distinguish them from the more 
conventional methods which consider only statis-
tically signiﬁ  cant genes as candidates for func-
tional analysis [4–7].
Two variations of gene expression signature 
analyses have thus far been implemented, distin-
guished by, primarily, whether the position of the 
genes in a rank ordered dataset of gene expression 
differences is taken into account or not. The ﬁ  rst 
major method to be described, gene set enrichment 
analysis (GSEA) is a non-parametric method in 
which the relative rank order of genes from a 
selected gene set is considered across the entire 
distribution of gene expression differences. This 
method essentially provides a weighting function 
which can identify subsets of genes within a gene 
list that are signiﬁ  cantly enriched in a positive or 
negative direction (up- or down-regulated). Various 
versions of this approach have been reported [8, 9] 
including an alternative approach which can be used 
to detect the simultaneous signiﬁ  cant enrichment 
of both up- and down-regulated genes within a 
single gene set [10].
In contrast to GSEA and the other related non-
parametric methods, the parametric analysis of gene 
expression (PAGE) approach for gene expression 
signature analysis [11] involves the calculation of 
a single parameter (for example, the mean or 
median of expression difference values) for both 
the data extracted from a dataset by a particular 
gene list as well as for the dataset as a whole. The 
value of the gene list parameter is then compared 
with the same parameter derived for the entire 
dataset and statistically signiﬁ  cant enrichment is 
indicated by a z score value (corrected for sample 
size). The parametric approach will not detect sub-
sets of regulated genes contained within a given 
gene list because all of the gene list values are sum-
marized in one aggregate parameter. Thus any 
distinction between sub-groups of genes within a 
given gene list is lost. On the other hand, a para-
metric approach such as PAGE is relatively easy to 
implement and, perhaps, even more importantly, as 
we will describe and demonstrate below, these 
parametric approaches are capable of being scaled-
up and streamlined for rapid and very efﬁ  cient 
high-throughput analysis of gene expression data.
Implementation
GSMA is currently implemented in the JMP desk-
top statistical discovery software from SAS as a 
series of customized JMP scripts (supplementary 
information, ﬁ  le 6–8). Run times on a Windows 
XP platform, 1.0 GHZ, 512MB RAM, varies 
directly in proportion to the size and number of the 
datasets as well as the size of the genelist (large 
combinations, particularly of genelists >500, may 
require processing overnight, e.g. processing of 
the asthma related datasets versus pathways gene 
lists, as shown in Figure 3A, has a run time of 
little under one hour). GSMA can be performed 
either on single (one-dimensional 1D GSMA) or 
multiple datasets (two-dimensional 2D GSMA). 
The output between the two versions differs pri-
marily on the data representations which are gen-
erated upon completion of the appropriate JMP 
scripts; all versions generate a ﬁ  le of GSMA z 
scores in tabular form. An additional variation 
available in both 1D and 2D GSMA is the substitu-
tion of median for mean calculations in order to 
reduce the inﬂ  uence of outliers on the computed 
GSMA z scores. 2D GSMA is available in a 51
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version 2 form which, in addition, to computing 
the basic z score matrix also captures the difference 
values for every gene in each list of a given gene 
set and automatically returns these results to an 
Excel workbook, using a separate worksheet for 
each list. Since this output is not practical to use 
for larger gene sets, it is usually incorporated into 
a second pass through the data with a subset of the 
original gene set tested for drill down purposes (for 
an example of the output of this process, see 
Fig. 3D below). GSMA scores are computed for 
each gene list for each dataset according to the 
algorithm ﬁ  rst described by Kim and Volsky [11]:
   Z  = (Sm − µ)*m
1/2 / σ
Where Sm is the mean of the difference metric 
values of genes for a given gene list and the size 
of the given gene list is m. The mean (µ) and stan-
dard deviation (σ) of the total difference metric 
values for a given microarray dataset are calculated 
for all genes.
GSMA is initiated by the user by running the 
appropriate JMP script. The user will first be 
prompted to upload a tab-delimited ﬁ  le containing 
one or more columns of pre-computed changes in 
gene expression which can be in the form of simple 
differences between the means, fold-changes, log 
ratios, or any other consistent difference metric 
(Fig. 1). Each column of gene expression differ-
ences is referred to as a dataset. The ﬁ  rst column 
in every ﬁ  le is devoted to gene IDs which are rep-
resented by the appropriate human gene symbols 
as accepted by the HUGO Gene Nomenclature 
Committee (mouse gene symbols must ﬁ  rst be 
converted to their human gene symbol counter-
parts). The user can choose to use a different gene 
identiﬁ  er (e.g. GenBank accession number) as long 
as care is taken to use the same identiﬁ  er for both 
the datasets and gene lists. The script will next 
prompt the user to upload a query ﬁ  le which must 
contain at least one row of genes identiﬁ  ed by 
HUGO gene symbols, as above, and again the ﬁ  rst 
column contains the gene set name (there are no 
restrictions on the naming convention for gene lists 
in a given gene set). Finally, the user is asked to 
name both the dataset and gene set ﬁ  les. Submis-
sion of this information starts the GSMA protocols 
which are completed in a time proportional to the 
complexity of both the datasets and the query lists 
which are being tested (highly complex dataset/
gene set combinations may require running the 
scripts overnight on most desktop PCs). A discussion 
of GSMA output and its interpretation will be the 
subject of the Results section below. The 2D 
GSMA script as well as sample GSMA datasets 
and a query gene list ﬁ  le are available from the 
supplementary information.
Results
1D GSMA
The simplest instance of GSMA (one-dimensional 
or 1D GSMA) tests one dataset (one column of 
data) of gene expression differences against a given 
gene set. Figure 2A shows an example of this form 
of GSMA in which GSMA z scores returns have 
been rank ordered and presented in the form of a 
bar graph with the largest positive z score at the 
top and the largest negative z score at the bottom. 
This axis of values corresponds to increasing 
positive or negative enrichment of gene expression 
for the genes in these lists as calculated between 
treatment and control. For this example, gene 
expression differences were calculated by taking 
the average of samples pre- and post-induction (by 
serum withdrawal) in a human model of myocyte 
differentiation of proliferating cells (myoblasts) to 
mature myotubes [12]. In order to simplify the 
analysis a series of highly replicated time course 
samples were collapsed into 2 groups for com-
parison.
It should be noted that gene sets are themselves 
lists of lists, as in this case, a compendium of 445 
separate gene lists (gene symbols only) was tested. 
Each list is composed of a variable number of genes 
grouped by having a particular transcription factor 
binding site in its upstream promoter region (Trans-
Fac gene set) [13]. Gene set lists may and often do 
have gene redundancies, ie,the same gene may 
appear in many different lists within a single gene 
set as, for example, does the JUND gene which is 
found in a total of 29 lists within the TransFac gene 
set. Each instance of JUND in a TransFac list cor-
responds to a different transcription factor binding 
site mapped within the JUND gene promoter. 
While the individual contribution of redundant 
genes is always the same for a particular dataset, 
the output from the various lists in which they are 
located is context-dependent and can be highly 
variable.
Figure 2B shows the thirty most highly 
enriched GSMA gene lists from the TransFac 52
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Figure 1. Screen shots of GSMA scripts implemented in JMP. Upon initiating the start-up of one of the GSMA scripts, the user is prompted 
to: A. up-load a tab-delimited ﬁ  le of gene expression differences, B. upload a tab delimited gene set query (list of lists), C. name the dataset 
and query lists, D. after the script ﬁ  nishes running, a matrix of z scores is returned for all lists in the gene set which exceed a pre-set 
signiﬁ  cance threshold for any given dataset.53
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gene set representing groups of genes whose 
overall expression has either increased during 
myotube formation or whose expression is more 
dominant at the myoblast stage. Gene lists cor-
responding to the E2F family of transcription 
factor binding sites are highly enriched in the 
myoblast direction relative to differentiated myo-
tube cells. E2F proteins are known to play a key 
role in the expression of genes required for the 
movement into and through the cell cycle pro-
gression and thus their transcription is empha-
sized in the rapidly dividing myoblast cells. Gene 
lists known to be related to myogenesis, on the 
other hand, are enriched in the myotube axis of 
differentiation including genes controlled by 
myocyte enhancer factor 2 (MEF2) a class of 
transcription factors essential for muscle devel-
opment, myogenin which is required not for the 
initiation of myogenesis but instead for skeletal 
muscle formation [14], RSRFC4 which recog-
nizes similar but distinct binding sites found in 
the promoters of both muscle-specific and 
'immediate early' genes [15]. HEB, a helix-loop-
helix protein, can modulate the DNA-binding 
ability of myogenic regulatory factors (MRFs) 
[16–18]. Isoforms of NFI proteins accumulate 
differentially in fast- and slow-twitch muscles 
and are thought to contribute to the molecular 
basis for skeletal muscle diversity [19]. The up-
regulation of genes associated with SREPB 
(sterol response element binding protein) is 
somewhat of a puzzle as this transcription factor 
is strongly associated with adipocyte determina-
tion and differentiation [20]. Both adipocytes and 
myocytes can be induced from the same multi-
potent mesodermal progenitor cell type [21] 
depending on the conditions used. It has been 
well established that peroxisome proliferator-
activated receptor γ (PPARγ) is an absolute 
requirement for adipocyte differentiation and 
although some statistically significant up-
regulation of expression of PPARγ was observed 
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Figure 2. Graphical representation of GSMA signiﬁ  cance scores for A. 114/445 genelists derived from the Transfac database [13] rank 
ordered from high to low on the basis of the GSMA z scores, and B. 30 of the most signiﬁ  cant TransFac gene lists which correspond to gene 
groups whose overall expression was either increased during myotube formation (positive z scores) or increased in myoblasts (negative 
z scores).54
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during myotube formation in these experiments, 
overall it remained at relatively low levels (data 
not shown). It is intriguing to speculate that per-
haps SREBP is generally up-regulated during 
differentiation in this cell type but only induces 
adipogenesis in the presence of a correspondingly 
robust increase of PPARγ.
2D GSMA
It is as of much value to investigate patterns of 
systematic enrichment within and between multiple 
experiments by clustering gene sets (Fig. 3) as it is 
to look for patterns of coordinate gene expression 
at the individual gene level. The use of gene expres-
sion signature analysis in this way has been previ-
ously suggested by others [9]. GSMA provides a 
straightforward and highly scalable method for 
analyzing very large combinations of datasets, gene 
sets, and the resulting GSMA values in a simple and 
efﬁ  cient manner. Figure 3 shows a composite of 
results of 2D GSMA analysis in which a pathway 
gene set containing 587 separate genelists was tested 
against 12 separate datasets derived from 3 cell types 
activated with 2 different antigenic stimuli (LPS and 
ambient particulate matter—APM [22]). Patterns of 
common pathway enrichment are clearly visible by 
clustering (unsupervised, single linkage, hierarchi-
cal clustering using uncentered Pearson correlations 
[23]), the GSMA z score matrix and generating a 
heat map of the results (Fig. 3A). An overlapping 
and robust response to antigenic stimuli is demon-
strated in both bronchiolar lavage macrophages 
(BAL) and peripheral blood monocytes (MON) but 
not in airway epithelium (Fig. 3B). The strongest 
interferon response in both immune cell types is 
induced by LPS at 6 hours. Overall response patterns 
to LPS treatment are subsiding in bronchial macro-
phages but continue to be prolonged in circulating 
monocytes after 20 hours post-induction. Graphical 
representation of the same data (Fig. 3C) emphasizes 
the relatively minor response of airway epithelial 
cells and the differential response of macrophages 
and monocytes to LPS and APM in terms of the 
magnitude of pathway involvement. The high 
granularity of GSMA data is demonstrated by pat-
terns of individual gene enrichment within a single 
example of a positively regulated gene list (Fig. 3D). 
The pattern of human asthma-related genes, on a 
gene-by-gene basis, almost exactly maps to the pat-
terns exhibited at the gene list level and, in addition, 
provides the end-user immediate access to the basic 
microarray data measurements—changes in 
expression at the individual gene evel. These genes 
are now conveniently organized by both function 
and experiment for further consideration.
GSMA and hypothesis evaluation
The reliability and usefulness of a newly intro-
duced data mining tool is often (and understand-
ably) evaluated by its ability to return information 
which is already well understood, previously 
documented, and accepted in other contexts. So, 
for example, in the clustering data in Figure 3 
above, the large overlap between stimulated bron-
chial macrophages and peripheral blood monocytes 
for pathways involved in the immune response was 
not surprising in the least, and neither was the 
relative absence of enrichment of these same path-
ways for airway epithelial cells subjected to the 
same treatments. These results are in fact, offered 
simply as a proof of principle that GSMA can 
produce logical and coherent outcomes given a 
large number of datasets and gene set gene lists. 
The next step for demonstrating the usefulness of 
a data-mining tool is to show evidence for the 
discovery of new knowledge. The following two 
cases are offered as examples of how GSMA can 
add value by systematically exploring relationships 
contained within gene expression data.
The case of the non-responsive patient
The use of GSMA is not restricted to testing data-
sets of changes in gene expression but can also be 
applied directly to gene expression intensity data as 
well. When the z transformation method is used for 
gene expression normalization [24], gene expression 
data is distributed evenly above and below zero in 
log10 space. When GSMA is applied directly to gene 
expression intensities, the average overall intensity 
for a given list of genes is translated directly into a 
corresponding GSMA z score with a high GSMA 
score (red) indicating that the genes for that par-
ticular list were highly expressed on average. Con-
versely, a low GSMA score (green) indicates an 
overall low level of gene expression for a given gene 
list. As previously mentioned, one of the advantages 
of GSMA is that gene lists can be derived from 
virtually any source and can be quickly and easily 
converted into testable gene sets. In the following 
example, good advantage was taken of the public 
on-line availability of lists of genes related to 
immune cell-speciﬁ  c expression developed from 55
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Figure 3. 2D GSMA results corresponding to 529 pathway-related gene lists tested independently on 12 separate datasets. A. Thumbnail 
image—heatmap of hierarchical clustering of GSMA z scores. B. Zoom image—highlighting an area of extensive pathway co-regulation 
shared by many but not all samples. C. GSMA z score data from 3B displayed in column format. D. Example of gene expression differences 
from a single enriched pathway (human asthma genes) for all samples. Samples were derived from multiple patients and stimulated in 
culture with lipopolysaccharide (LPS) or ambient particulate matter (APM) for 6 and 20 hours. BAL = bronchial lavage macrophages, MON 
= monocytes, EPI = airway epithelial cells.
experimental data by researchers at Genentech Inc. 
[25]. Figure 4A shows the gene numbers by list type 
contained within the IRIS (Immune Response 
In Silico) gene set. Bronchial lavage macrophages 
and peripheral blood monocytes are easily 
distinguished from airway epithelial cells by virtue 
of their dramatically different expression of immune 
cell speciﬁ  c genes in Figure 4B. Macrophage and 56
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Figure 4. Application of GSMA directly to gene expression intensities. A. Bar graph illustrating the distribution of the numbers of speciﬁ  c 
immuno-dominant genes compiled from a comprehensive compendium of microarray human gene expression data from six key immune 
cell types [25]. B. Hierarchical clustering of GSMA results in which the average gene expression intensities of the various cell types and 
treatments tested (vertical axis) were evaluated using the IRIS gene set and assigned a z score value on the basis of enrichment for the 
immune cell types as shown (horizontal axis). GSMA results for this visualization were clustered by IRIS immune cell type while the exper-
imental cell type (BAL, MON, & EPI) and the treatment (LPS & APM) order was held constant. 
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monocyte cells are, not surprisingly, enriched for 
the expression of genes associated with myeloid, 
monocyte and multiple immune cell types while 
airway epithelial show no strong enrichment for any 
group of immune related genes. Interestingly, mono-
cyte-speciﬁ  c genes are induced in both BAL and 
MON cells with antigenic stimuli but otherwise they 
remain at moderate or low levels in resting cells. As 
expected, the monocyte speciﬁ  c marker genes are 
mobilized as a group in a more robust fashion in 
monocytes than macrophages for both LPS and 
APM at the time points tested. A closer examination 
of the GSMA scores for the monocytes and the 
monocyte-speciﬁ  c gene list reveals a noteworthy 
anomaly. One patient (41, 42, … 45) appears not 
to be generating any strong monocyte-speciﬁ  c 
gene expression signature response to antigen in 
cultured monocytes while at the same time this 
cell population is instead distinctly and uniquely 
enriched for lymphocyte-speciﬁ  c gene expression. 
The BAL cells for the same patient (36, 37, … 40) 
are the primary contributors to a monocyte-speciﬁ  c 
gene expression response in BAL cells overall. It 
is tempting to speculate that this patient may have 
been undergoing an active inﬂ  ammatory response 
at the time of cell harvest. It is also possible (but 
less likely) that this data could be the result of 
some variation in the collection procedure. What 
is clear, however, is that this patient is showing a 
differential response pattern which otherwise 
would have gone undetected without GSMA 
analysis and the inclusion of this data could 
adversely affect both the power and statistics of 
the study in question.
An hypothesis overturned
Recent work by ourselves and others has demon-
strated widespread patterns of mRNA decay rate 
regulation in response to different biological stimuli 
[26–28]. The data supporting these conclusions has 
been generated primarily through direct comparison 
of nascent gene transcription (nuclear run-on RNA; 
NRO RNA) to changes in gene expression as mea-
sured at the whole cell level (Total RNA). Although 
these results have been validated by Actinomycin 
D chase assays on nuclear run-on RNA for selected 
genes [28], the vast majority of these observations 
are made by inference, through the recording of 
large and consistent changes in gene expression as 
measured in total RNA without a concomitant 
change in gene expression in the NRO RNA even 
when allowing for a time lag for mRNA processing 
and transport. These studies taken together suggest 
that genome wide post-transcriptional regulation of 
cellular mRNA levels is a widespread phenomenon 
and can account for as much as 50% of the changes 
in gene expression as measured by conventional 
microarray.
An example of this type of study is seen in 
Figure 5A in which changes in gene expression are 
contrasted between NRO and Total RNA across a 
one hour time course of T cell activation. Consis-
tent and overlapping regulation of gene expression 
across the entire length of the time course can be 
seen for both NRO and Total RNA. Even greater 
numbers of cellular mRNAs, however, are clearly 
being regulated while relatively low or no regula-
tion can be detected for the same genes in the NRO 
RNA. Initially our working hypothesis was that the 
demonstrably large numbers of post-transcriptional 
changes in gene expression would explain why it 
has been difﬁ  cult to routinely correlate changes in 
total cellular gene expression with common 
upstream promoter elements in organisms higher 
than yeast [29]. For example, in our own work, we 
were able to demonstrate the enrichment of genes 
containing either the NFKB or NFAT families 
of transcription factor binding sites during the 
activation of Jurkat T cells in NRO but not total 
RNA [30].
GSMA analysis of this dataset (Fig. 5B) shows 
the distinctive and contrasting patterns of pathway 
enrichment between the NRO and Total RNA 
measurements during Jurkat T cell activation. 
NRO gene transcription heavily favors the up-
regulation of speciﬁ  c pathways (in other words, 
turning on gene expression occurs more fre-
quently than turning it off) while pathway enrich-
ments for total RNA are approximately evenly 
divided between up- and down-regulation 
(Fig. 6B). The NRO pattern of pathway enrich-
ment, in particular, shows a dramatic shift of 
emphasis between 30 and 60 minutes of activation 
including the turning on of genes in NFKB path-
ways (supplementary data) as predicted by our 
previous ﬁ  ndings [30].
Similarly, when GSMA was performed on the 
same datasets with the TransFac gene lists, 
the NRO and total RNA patterns of enrichment 
were again quite different (Fig. 5C). The coordi-
nated increase in the expression of genes correlated 
by TransFac gene lists appears to gather momen-
tum up to a spike at 30 minutes in NRO RNA while 
in the total RNA there is a slight but consistent 58
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Figure 5. Characterization of contrasting nuclear run-on (NRO) and total RNA gene expression during a one hour time course (in minutes 
as indicated) of T cell activation. A. Heat map of hierarchical clustering of differential gene expression of NRO and total RNA up- (red) or 
down- (green) regulated from their respective baselines. B. 2D GSMA pathway results using the same dataset as in 5A for analysis. C. 2D 
GSMA transcription factor binding site (TFBS - TransFac) results using the same dataset as in 5A for analysis.
bias towards up-regulation of TransFac gene 
lists across the time course of activation (Fig. 6C). 
The appearance of substantial regulation correlated 
by the TransFac gene lists in total RNA was sur-
prising given that many of these genes we believe 
to be primarily regulated by changes in mRNA 
decay rates and therefore we did not expect to 
detect a particularly large association with tran-
scriptional control elements in this analysis. In 
order to focus directly on the question of whether 
or not stability regulated genes somehow continue 
to maintain a functional association correlated to 
the control of their transcription, a subset of the 
total RNA genes selected as most likely to be sta-
bility regulated genes (Fig. 6A) was tested again 
with the TransFac genelists and the results (Fig. 6D) 
showed substantial up and down regulation of Total 
RNA genes correlated by the presence of common 
transcription factor binding sites while the 
corresponding NRO data generated little or no 
GSMA z score values. It became clear via this 
analysis that there exists a good possibility that the 
functional characteristics predicted among genes 
by the presence of common upstream promoter 
elements (e.g. transcription factor binding sites; 
TFBS) can be found not only in the coordinated 
expression of nascent gene transcription but also 
carries over to guide at least a portion of post tran-
scriptional regulation as well. In other words, the 
functional associations which result in coordinated 
gene expression at the transcriptional level con-
tinue to have relevance in later whole cell regula-
tion of gene expression in which, presumably, the 
presence or absence of a TFBS no longer has a 
direct mechanistic relevance. This ﬁ  nding directly 
contradicted our previous assumptions and was 59
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Figure 6. Characterization of pathway and TFBS gene set enrichment between nuclear run-on (NRO) and total RNA during a time course 
of T cell activation. A. Subset of stability regulated genes. B. Comparison of cumulative pathway enrichment between nuclear-run on (NRO) 
and total RNA during T cell activation. C. Comparison of cumulative transcription factor binding site (TransFac) enrichment between nuclear-
run on (NRO) and total RNA during T cell activation. In both 6B & 6C above; -U = the sum of all positively enriched gene lists, -D = the sum 
of all negatively enriched gene lists, -M = the sum of all enriched pathways. D. Speciﬁ  c TFBS (TransFac) gene set enrichment in total but 
not NRO RNA for a selected set of stability regulated genes.
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only suggested and revealed by GSMA analysis of 
patterns of shared TFBS in these datasets.
Discussion
The key to effective data-mining of gene expres-
sion data rests not only in the kinds of questions 
asked but also the ease and efﬁ  ciency which the 
answers can be obtained. GSMA offers a simple 
but effective tool for rapidly exploring speciﬁ  c 
patterns of gene enrichment by groups across a 
very wide range of experiments. GSMA has a 
simple user-friendly interface (Fig. 1), running 
scripts in JMP, an inexpensive and widely available 
windows version of SAS. The end-user supplies 
an input of gene expression data annotated with 
HUGO gene symbols and a second input of gene 
lists similarly annotated. The user has the option 
(script dependent) for a 1D (Fig. 2) or 2D (Fig. 3) 
analysis, as well as specifying whether to use the 
mean or median in calculating the gene enrichment 
scores. In addition, there is also a GSMA 2D ver-
sion which will return not only the matrix of GSMA 
z scores but will also isolate the input expression 
data for each gene list of a given gene set, each 
directly to a separate Excel worksheet (an example 
of a chart constructed directly from the data con-
tained on one of these sheets is shown in Fig. 3D). 
We ﬁ  nd that this option works best for a limited 
number of genelists (10–20) simply in terms of 
practicability and is particularly useful for drill-
down purposes.
GSMA can be used for comparing changes in 
gene expression between many different experi-
ments or for testing for group-wise changing pat-
terns of normalized gene expression intensities 
directly. Examination of gene expression intensi-
ties using a gene set speciﬁ  c for immune cell 
expression dominance clearly revealed an anoma-
lous response from one of the patients tested in the 
asthma dataset (Fig. 4A). This discovery is both 
of clinical relevance to the study being conducted 
as well as illustrating the ﬂ  exibility of GSMA for 
visualizing complex datasets in a creative and 
easily customized fashion.
Finally, in Figures 5 and 6, we provide an 
example of how GSMA was used to discover 
unexpected patterns of TFBS enrichment in the 
upstream promoter regions of genes considered to 
be primarily post-transcriptionally regulated. This 
ﬁ  nding was only made possible by the ease with 
which GSMA can be used to interrogate gene 
expression data comprehensively using very large 
gene sets (the TransFac gene set contains 445 
separate gene lists), a task that just a short time ago 
would have been prohibitive for a moderately sized 
laboratory solely for the purposes of exploration. 
It was unclear initially whether or not searching 
gene expression data by individual TFBS would 
even be appropriate given the full complexity of 
promoter architecture [31, 32]. It is now becoming 
apparent that there are indeed strong correlations 
to be found between generalized gene expression 
and the presence of individual common promoter 
elements as found by ourselves and others [33].
Conclusion
As the amount of gene expression data expands 
exponentially and the volume of stored data avail-
able in repositories both public and private surges, 
it becomes increasingly important to develop meth-
ods which can accelerate the process of hypothesis 
testing at multiple levels of either the individual 
experiment, across projects, and even within an 
entire database [34]. GSMA and similar approaches 
will be useful for rapidly testing original as well as 
archived gene expression datasets for speciﬁ  c gene 
expression enrichment at the group level using either 
preset gene lists (pathways, promoter elements, 
disease association, etc) or empirically derived gene 
expression signatures [2]. These methods should be 
sufﬁ  ciently permissive so as to allow for the natural 
variation inherent to biological systems while at the 
same time be sufﬁ  ciently quantitative to facilitate 
the prioritizing of new knowledge and help to orga-
nize it in a coherent way.
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Additional ﬁ  les
Additional ﬁ  le 1. Excel workbook, Cheadle et 
al.– 1D GSMA myotube differentiation versus 
TransFac gene lists - z score matrix for Figure 2.
Additional ﬁ  le 2. Excel workbook, Cheadle et al. 
– 2D GSMA asthma dataset versus Pathways gene 
lists - z score matrix for Figure 3, also gene speciﬁ  c 
difference values for the human asthma genes for 
Figure 3D.
Additional ﬁ  le 3. Excel workbook, Cheadle et al. – 2D 
GSMA asthma dataset versus IRIS gene lists - z 
score matrix for Figure 4.
Additional ﬁ  le 4. Excel workbook, Cheadle et al. 
– 2D GSMA T cell activation, NRO and total RNA 
versus Pathways and TransFac gene lists - z score 
matrix for Figure 5 (data for all NRO and total 
RNA gene expression differences (Fig. 5A) avail-
able at [30]).
Additional ﬁ  le 5. Excel workbook, Cheadle et al. 
– Stability-regulated genes. 
Additional ﬁ  le 6. JMP script, Cheadle et al. – 2D 
GSMA, medians, all values reported.
Additional ﬁ  le 7. TAB text ﬁ  le, Cheadle et al. – 
test dataset (w/ ﬁ  les 6 and 8, will generate data 
for Fig. 4B.)
Additional ﬁ  le 8. JMP ﬁ  le, Cheadle et al. – test 
genelist (w/ ﬁ  les 6 and 7, will generate data for 
Fig. 4B.)